TRCT
SILO icon

Tower Research Capital (TRC)’s Silo Pharma SILO Stock Holding History

Tower Research Capital (TRC)’s Portfolio SILO Stock Details SILO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.12K Buy
181
+69
+62% +$441 ﹤0.01% 4885
2026
Q1 		$603 Sell
112
-1
-0.9% -$5 ﹤0.01% 4830
2025
Q4 		$576 Sell
113
-1
-0.9% -$7 ﹤0.01% 4868
2025
Q3 		$1.18K Sell
114
-2
-2% -$20 ﹤0.01% 4857
2025
Q2 		$1.09K Buy
116
+19
+20% +$218 ﹤0.01% 4878
2025
Q1 		$1.7K Sell
97
-206
-68% -$4.61K ﹤0.01% 4665
2024
Q4 		$4.05K Buy
303
+32
+12% +$495 ﹤0.01% 4531
2024
Q3 		$4.47K Sell
271
-173
-39% -$3.69K ﹤0.01% 4535
2024
Q2 		$6.66K Buy
444
+149
+51% +$3.81K ﹤0.01% 4554
2024
Q1 		$8.64K Sell
295
-172
-37% -$4.09K ﹤0.01% 3987
2023
Q4 		$10.1K Buy
467
+141
+43% +$3.2K ﹤0.01% 4294
2023
Q3 		$8.17K Buy
326
+4
+1% +$119 ﹤0.01% 4384
2023
Q2 		$9.91K Sell
322
-44
-12% -$1.43K ﹤0.01% 4198
2023
Q1 		$12K Buy
366
+288
+369% +$10.5K ﹤0.01% 4120
2022
Q4 		$4K Buy
+78
New +$4.56K ﹤0.01% 5062

Other funds holding SILO

AI
AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
HI
Harbour Investments Madison, Wisconsin $7.43B AUM 24.49% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Tower Research Capital (TRC)'s SILO Position: Q2 2026 in Review

Tower Research Capital (TRC) increased its Silo Pharma (SILO) stake by 62% in Q2 2026, buying an estimated $441 and bringing the position to 181 shares worth $1.12K. The position accounts for ﹤0.01% of the portfolio, ranked #4885.

Tower Research Capital (TRC) first reported a position in SILO in Q4 2022 and has held it in 15 quarters since. The position peaked at $12K in Q1 2023. 9 funds tracked by Wall St. Rank hold SILO as of Q2 2026.

  • Tower Research Capital (TRC) held 181 shares of Silo Pharma worth $1.12K as of Q2 2026.
  • Tower Research Capital (TRC) bought 69 Silo Pharma shares in Q2 2026, an estimated $441.
  • Silo Pharma made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q2 2026, its #4885 holding.
  • Tower Research Capital (TRC) first reported a position in Silo Pharma in Q4 2022 and has held it in 15 quarters since.
  • Tower Research Capital (TRC)'s Silo Pharma position peaked at $12K in Q1 2023.
  • 9 funds tracked by Wall St. Rank held Silo Pharma as of Q2 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.